Health and WellBeing
Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign.
Credit Bloomberg Quicktake: Now
J&J Covid-19 Vaccine Is 66% Effective in Global Clinical Trial
